Discover how integrated multi-omics analysis is transforming early lung adenocarcinoma diagnosis and treatment through comprehensive molecular profiling.
Discover how MUC1 protein and the MAPS signature predict lung adenocarcinoma outcomes and revolutionize cancer treatment approaches.